Patient and external quality assessment samples demonstrate similar bias between manufacturers in titer of antibodies to nuclear antigens: Implications for commutability

Susan L. Fink; Michael A. Linden; Mark H. Wener

doi:10.5858/arpa.2021-0060-le

Patient and external quality assessment samples demonstrate similar bias between manufacturers in titer of antibodies to nuclear antigens: Implications for commutability

Susan L. Fink
, Michael A. Linden
, Mark H. Wener

Laboratory Medicine and Pathology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	919-920
Number of pages	2
Journal	Archives of Pathology and Laboratory Medicine
Volume	145
Issue number	8
DOIs	https://doi.org/10.5858/arpa.2021-0060-le
State	Published - Aug 1 2021

Bibliographical note

Funding Information:
Fink was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under awards K08AI119142, R21AI131269, and R21AI153487.

Publisher link

10.5858/arpa.2021-0060-le

Find It

Find It at U of M Libraries

Cite this

Patient and external quality assessment samples demonstrate similar bias between manufacturers in titer of antibodies to nuclear antigens: Implications for commutability. / Fink, Susan L.; Linden, Michael A.; Wener, Mark H.
In: Archives of Pathology and Laboratory Medicine, Vol. 145, No. 8, 01.08.2021, p. 919-920.

Research output: Contribution to journal › Letter › peer-review

@article{d26db99c1b5b45368f5e91e8763d6e62,

title = "Patient and external quality assessment samples demonstrate similar bias between manufacturers in titer of antibodies to nuclear antigens: Implications for commutability",

author = "Fink, \{Susan L.\} and Linden, \{Michael A.\} and Wener, \{Mark H.\}",

note = "Funding Information: Fink was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under awards K08AI119142, R21AI131269, and R21AI153487.",

year = "2021",

month = aug,

day = "1",

doi = "10.5858/arpa.2021-0060-le",

language = "English (US)",

volume = "145",

pages = "919--920",

journal = "Archives of Pathology and Laboratory Medicine",

issn = "0003-9985",

publisher = "College of American Pathologists",

number = "8",

}

TY - JOUR

T1 - Patient and external quality assessment samples demonstrate similar bias between manufacturers in titer of antibodies to nuclear antigens

T2 - Implications for commutability

AU - Fink, Susan L.

AU - Linden, Michael A.

AU - Wener, Mark H.

N1 - Funding Information: Fink was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under awards K08AI119142, R21AI131269, and R21AI153487.

PY - 2021/8/1

Y1 - 2021/8/1

UR - https://www.scopus.com/pages/publications/85112016891

UR - https://www.scopus.com/pages/publications/85112016891#tab=citedBy

U2 - 10.5858/arpa.2021-0060-le

DO - 10.5858/arpa.2021-0060-le

M3 - Letter

C2 - 34313715

AN - SCOPUS:85112016891

SN - 0003-9985

VL - 145

SP - 919

EP - 920

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

IS - 8

ER -

Patient and external quality assessment samples demonstrate similar bias between manufacturers in titer of antibodies to nuclear antigens: Implications for commutability

Bibliographical note

Publisher link

Find It

Other files and links

Cite this